KLCM
NVO

KG&L Capital Management’s Novo Nordisk NVO Stock Holding History

KG&L Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,199
Closed -$275K – 207
2024
Q4 		$275K Sell
3,199
-664
-17% -$71.8K 0.09% 160
2024
Q3 		$460K Sell
3,863
-224
-5% -$29.9K 0.15% 131
2024
Q2 		$583K Sell
4,087
-75
-2% -$9.94K 0.2% 108
2024
Q1 		$534K Buy
4,162
+1,217
+41% +$145K 0.21% 103
2023
Q4 		$305K Buy
2,945
+19
+0.6% +$1.88K 0.13% 136
2023
Q3 		$266K Buy
2,926
+26
+0.9% +$2.29K 0.13% 129
2023
Q2 		$235K Buy
2,900
+20
+0.7% +$1.63K 0.11% 135
2023
Q1 		$229K Sell
2,880
-386
-12% -$27.4K 0.12% 119
2022
Q4 		$221K Buy
+3,266
New +$191K 0.13% 118
2022
Q3 		– Sell
-4,122
Closed -$230K – 133
2022
Q2 		$230K Sell
4,122
-1,620
-28% -$89.9K 0.12% 113
2022
Q1 		$319K Sell
5,742
-474
-8% -$24.3K 0.13% 109
2021
Q4 		$348K Hold
6,216
– – 0.14% 112
2021
Q3 		$298K Buy
6,216
+120
+2% +$5.8K 0.13% 122
2021
Q2 		$255K Sell
6,096
-6
-0.1% -$233 0.12% 127
2021
Q1 		$206K Sell
6,102
-160
-3% -$5.7K 0.1% 131
2020
Q4 		$218K Buy
+6,262
New +$216K 0.12% 133

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

KG&L Capital Management's NVO Position: Q1 2025 in Review

KG&L Capital Management sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 3,199 shares — an estimated $275K sold.

KG&L Capital Management first reported a position in NVO in Q4 2020 and held it in 16 quarters. The position peaked at $583K in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • KG&L Capital Management reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • KG&L Capital Management sold 3,199 Novo Nordisk shares in Q1 2025, an estimated $275K.
  • KG&L Capital Management first reported a position in Novo Nordisk in Q4 2020 and held it in 16 quarters.
  • KG&L Capital Management's Novo Nordisk position peaked at $583K in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on KG&L Capital Management's 13F filing for Q1 2025, filed 23 Apr 2025.